RET and multiple endocrine neoplasia type 2: Germline loss-of-function variants in RET cause Hirschsprung’s disease (HSCR), a congenital intestinal malformation (2), while activating variants cause multiple endocrine neoplasia type 2 (MEN 2), an autosomal dominantly inherited cancer-susceptibility syndrome (3, 4).